Author Archives: Pete Shuster

CEO and Owner at Neuromics-Biotechnology industry

Bioreagents company specializing in providing reagents and methods for the Neuroscience Research Community. As a natural extension, we are growing our catalog to serve Diabetes/Obesity and Cancer Research.

In addition to antibodies, proteins, primary neurons and stem cell reagents, we have unique products expertise in delivering DsiRNA both in vivo and in vitro.

TCE and Parkinson’s

This post introduces a new twist to “News Behind the Neuroscience News”. This report was graciously submitted by Ms Pamela Brown of associatesdegree.com. I welcome her initiative in submitting this. On a side note, when I did factory work in the 1970s, trichloroethylene was a universal solvent used to clean parts. Wow. We will add [...]

Opioid-Induced Hyperalgesia and CaMKII alpha

Many of my backstories have featured Pain Researchers.  In several, I have featured use of our our i-Fect ™ Transfection Kit for enhancing the delivery of siRNA in vitro and in vivo to study the expression of genes invovled in Neuropathic and Nociceptive Pain.
I am excited to present a recent publication that includes use of this kit [...]

Hope for Stroke Victims-Transplanting STEMEZ hNP1 Cells

Hope for Stroke Victims-Transplanting STEMEZ hNP1 Cells
Posted using ShareThis

Featuring Dr. Pat Carr

Amyotrophic Lateral Sclerosis (ALS)-New Twists on Root Causes

Teacher, Mentor and Friend    Dr. Pat Carr has been a key figure in helping shape the direction of my company. He has a gift for communicating the nuances of his research and coaching me on how to best serve labs like his. Based on these interactions, it came as no surprise [...]

Spinal Cord Injury Repair

I wanted to feature yet more research on spinal cord injury repair.
Dr. Mark Tuszynski and his team of researchers at USCD recently published work that tested their hypothesis that chemotropic mechanisms would guide regenerating spinal cord axons to appropriate brainstem targets.
Laura Taylor Alto, Leif A Havton, James M Conner, Edmund R Hollis II, Armin Blesch & [...]

STEMEZ hN2 Human Neurons Data

STEMEZ hN2 Human Neurons-electro-physiology data.

Gary Johnson-Apoptosis Ace

About Gray
1994-present-President, ICT
1993-1996-Conjugation Chemist, R&D Systems
19989-1993-Supervisor Protein Conjugation & ELISA Development Group, Solvay Animal Health
1986-1989-Immunologists, Biosciences Lab, 3M
1976-1986-Various Lab, U of MN
Gary’s Conatct Info:

gary@immunochemistry.com

952-888-8788  

 

Inventing Better Ways to Measure Apoptosis 
This profile features another Scientist Entrepreneur. Dr Gary Johnson is the Founder and President of Immunochemistry Technologies LLC (ICT). His company manufactures kits that have the [...]

Delivering 27mer DsiRNAs to Mice DRGs

DsiRNA was delivered in mice via IT injection using i-Fect. This added further support to the idea that the very potent DsiRNA coupled with a cationic delivery system that works in neurons is a very effective way to study the role of various genes in CNS function.

Advancing the Study of Apoptosis

Featuring Gary Johnson and his team at Immunochemistry Technologies LLC.
The ability to accurately measure apoptosis processes is a core  research component for many of our customers and colleagues.  Neuromics has leveraged our growing partnership with Gary and ICT to meet the exacting requirements of  Researchers studying apoptosis.
I am excited to be featuring Gary and his company in our [...]

Knockdown of rSNSR1 in vivo

I have featured successes with delivering siRNA in vivo in this blog. These included stories on Dr. Philipe Serrat and his team at the University of Sherbrooke and Dr. Mark Behlke’s work at Integrated DNA and Dicerna.
I am pleased to report the parade of success with use our i-FectTM in vivo grows. 
Here’s the most recent study:
Christian Ndong, [...]